Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
Aqua (Water), Glycerin, Ectoin, Polyglyceryl-10 Oleate, Coco-Caprylate/Caprate, Isononyl Isononanoate, Dimethyl Isosorbide, Panthenol, Carnitine, Tocopherol, Copper Tripeptide-1, Oxidized Glutathione, Ergothioneine, Tropolone, Copper Lysinate/Prolinate, Acetyl Hexapeptide-8, Methylglucoside Phosphate, Hydroxyethylcellulose, Saccharide Isomerate, Ethylhexylglycerin, Sodium Gluconate, Sclerotium Gum, Disodium Phosphate, Sodium Phosphate, Caprylyl Glycol, Propanediol, 1,2-Hexanediol, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Citric Acid, Polysorbate 60, Sodium Hydroxide, Polysorbate 20, Phenoxyethanol For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption
If you inject only once a day, the peptide disappears from your system for most of that 24-hour window
As always, its essential to consult with a healthcare provider to determine the best course of action for your specific health needs
4 Active Phase (Typically 4 to 12 Weeks) You administer the peptide on the schedule prescribed
